X-COR Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

X-COR Therapeutics General Information

Description

Developer of an extracorporeal CO2 removal device designed to treat acute respiratory failure. The company's device uses ultra-low-blood flow to treat patients with symptomatic lung failure with an accompanying control algorithm that is based on machine-learning techniques, enabling patients to get affordable and accessible therapy than existing comparable extracorporeal devices that often require flows and specialized physician interventions.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 701 East Pratt Street
  • Baltimore, MD 21202
  • United States
Primary Industry
Therapeutic Devices
Corporate Office
  • 701 East Pratt Street
  • Baltimore, MD 21202
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

X-COR Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Out of Business 15-Sep-2025 Completed Out of Business
11. Accelerator/Incubator 01-Feb-2025 Completed Generating Revenue
10. Grant 25-Dec-2021 Completed Generating Revenue
9. Seed Round 23-Mar-2020 Completed Generating Revenue
8. Accelerator/Incubator 07-May-2019 Completed Generating Revenue
7. Grant 24-Apr-2019 Completed Generating Revenue
6. Seed Round 21-Feb-2019 Completed Generating Revenue
5. Accelerator/Incubator 01-Jun-2018 Completed Generating Revenue
4. Grant 03-May-2018 $25K Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2018 Completed Startup
To view X-COR Therapeutics’s complete valuation and funding history, request access »

X-COR Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 1
To view X-COR Therapeutics’s complete cap table history, request access »

X-COR Therapeutics Patents

X-COR Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025174956-A1 Mass transfer device for the treatment of biological fluids and methods of use Pending 14-Feb-2024
EP-3681554-B1 Systems for extracorporeal removal of carbon dioxide Active 17-Sep-2017
CA-3075762-A1 Systems, devices, and methods for extracorporeal removal of carbon dioxide Pending 17-Sep-2017
EP-3681554-A2 Systems, devices, and methods for extracorporeal removal of carbon dioxide Active 17-Sep-2017
EP-3681554-A4 Systems, devices, and methods for extracorporeal removal of carbon dioxide Active 17-Sep-2017 A61M1/1698
To view X-COR Therapeutics’s complete patent history, request access »

X-COR Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

X-COR Therapeutics FAQs

  • When was X-COR Therapeutics founded?

    X-COR Therapeutics was founded in 2017.

  • Where is X-COR Therapeutics headquartered?

    X-COR Therapeutics is headquartered in Baltimore, MD.

  • What is the size of X-COR Therapeutics?

    X-COR Therapeutics has 2 total employees.

  • What industry is X-COR Therapeutics in?

    X-COR Therapeutics’s primary industry is Therapeutic Devices.

  • Is X-COR Therapeutics a private or public company?

    X-COR Therapeutics is a Private company.

  • What is X-COR Therapeutics’s current revenue?

    The current revenue for X-COR Therapeutics is .

  • How much funding has X-COR Therapeutics raised over time?

    X-COR Therapeutics has raised $2.8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process